Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


I-Mab : First Patient Dosed In U.S. Phase 1 Study Of Protollin For Treatment Of Alzheimer's Disease


RTTNews | Dec 8, 2021 08:09AM EST

08:09 Wednesday, December 8, 2021 (RTTNews) - I-Mab : First Patient Dosed In U.S. Phase 1 Study Of Protollin For Treatment Of Alzheimer's Disease

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC